Fingolimod - PDFSEARCH.IO - Document Search Engine

Fingolimod
Results: 83

#	Item
41	MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Multiple Sclerosis Agents a. Add to Reading List Source URL: www.dpw.state.pa.us Language: English - Date: 2014-07-24 10:00:03 Pharmacology Medicine Multiple sclerosis Clinical pharmacology Medical prescription Patient safety Teriflunomide Dimethyl fumarate Fingolimod Chemistry Organic chemistry Immunosuppressants
42	General Information about ALS TDI’s Phase IIA Clinical Trial of TDI-132 (Gilenya™) In 2009, the ALS Therapy Development Institute discovered the costimulatory pathway as a novel disease target as the result of a larg Add to Reading List Source URL: www.als.net Language: English - Date: 2013-02-08 12:41:22 Research Science Motor neurone disease ALS Therapy Development Institute Design of experiments Pharmaceutical industry Amyotrophic lateral sclerosis Clinical trial Fingolimod Health Rare diseases Clinical research
43	MODEL APPEAL LETTER – FINGOLIMOD (Gilenya) Today’s Date Plan Name Plan Address Plan Address: Dear Sir or Ms.: Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-01-15 23:37:00 Multiple sclerosis Immune system Cytokines Diols Fingolimod Antivirals Interferon beta-1a Sphingosine-1-phosphate Interferon Medicine Immunology Immunosuppressants
44	Webcast Transcript What’s new in MS research and treatment Jun 30, 2010 – 1:00-2:30PM ET 1 Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-01-07 18:35:44 Health Myelin Fingolimod Progressive multifocal leukoencephalopathy Chronic cerebrospinal venous insufficiency Blood–brain barrier Neuroregeneration Embryonic stem cell Natalizumab Multiple sclerosis Medicine Biology
45	Microsoft Word - draft Progressive_MS.docx Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-07-07 15:03:11 Health Natalizumab Amyotrophic lateral sclerosis Fingolimod Treatment of multiple sclerosis Therapies under investigation for multiple sclerosis Multiple sclerosis Immunology Immune system
46	PRIOR AUTHORIZATION POLICY Gilenya™ (fingolimod capsules Novartis) To Initiate a Coverage Review, Call[removed] Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-01-29 12:46:53 Cytokines Medicine Immunosuppressants Autoimmune diseases Treatment of multiple sclerosis Glatiramer acetate Interferon beta-1a Fingolimod Natalizumab Immunology Immune system Multiple sclerosis
47	QuarterWatch Monitoring FDA MedWatch Reports Signals for Fingolimod and Infliximab April 5, 2012 Data from 2011 Quarter 2 Add to Reading List Source URL: www.ismp.org Language: English - Date: 2012-04-04 07:46:28 Pharmacology Immunosuppressants Multiple sclerosis Medical terms Monoclonal antibodies Adverse Event Reporting System Fingolimod Infliximab Adverse event Medicine Health Chemistry
48	(2) State of New Product Development (As of July 29, 2014) i. New Drugs Development code Category Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-07-28 22:32:40 Immunosuppressants Influenza vaccine Vaccines Hereditary angioedema Fingolimod Diabetes mellitus Metformin Receptor antagonist Diabetic nephropathy Health Medicine Diabetes
49	La FDA Aprueba Fingolimod — Nombre Comercial Gilenya — Primera Terapia Oral Modificadora de la Enfermedad para las formas de EM con recaídas — Se espera esté disponible para recetarse en las próximas semanas Add to Reading List Source URL: www.nationalmssociety.org Language: Spanish - Date: 2014-01-07 18:07:49
50	APPENDIX D SASKATCHEWAN MS DRUGS PROGRAM PROCEDURE FOR OBTAINING COVERAGE OF MS DRUGS UNDER THE DRUG PLAN  Add to Reading List Source URL: formulary.drugplan.health.gov.sk.ca Language: English - Date: 2014-08-28 15:44:53 Medicine Immunosuppressants Autoimmune diseases Neurological disorders Glatiramer acetate Natalizumab Fingolimod Major depressive disorder Stroke Multiple sclerosis Immunology Immune system

UPDATE